Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 329

1.

Ramucirumab in advanced hepatocellular carcinoma and elevated alpha-fetoprotein following sorafenib: outcomes by prior transarterial chemoembolisation from two randomised, double-blind, placebo-controlled phase 3 studies (REACH-2 and REACH).

Meyer T, Finn R, Kudo M, Kang Y, Yen C, Galle P, Llovet J, Assenat E, Brandi G, Motomura K, Okusaka T, Hubner R, Karwal M, Baron A, Ikeda M, Liang K, Wang C, Widau R, Schelman W, Zhu A.

Ann Oncol. 2019 Jul;30 Suppl 4:iv133. doi: 10.1093/annonc/mdz154.020. Epub 2019 Dec 4. No abstract available.

PMID:
32085038
2.

Asbestos and Intrahepatic Cholangiocarcinoma.

Brandi G, Tavolari S.

Cells. 2020 Feb 12;9(2). pii: E421. doi: 10.3390/cells9020421. Review.

3.

Specific Toxicity of Maintenance Olaparib Versus Placebo in Advanced Malignancies: A Systematic Review and Meta-analysis.

Ricci AD, Rizzo A, Novelli M, Tavolari S, Palloni A, Tober N, Abbati F, Mollica V, DE Lorenzo S, Turchetti D, DI Marco M, Brandi G.

Anticancer Res. 2020 Feb;40(2):597-608. doi: 10.21873/anticanres.13989.

PMID:
32014900
4.

Dynamic optic nerve sheath diameter changes upon moderate hyperventilation in patients with traumatic brain injury.

Klinzing S, Hilty M, Bechtel-Grosch U, Schuepbach RA, Bühler P, Brandi G.

J Crit Care. 2020 Jan 9;56:229-235. doi: 10.1016/j.jcrc.2020.01.008. [Epub ahead of print]

PMID:
31982696
5.

Listeriosis Outbreak in South Africa: A Comparative Analysis with Previously Reported Cases Worldwide.

Kaptchouang Tchatchouang CD, Fri J, De Santi M, Brandi G, Schiavano GF, Amagliani G, Ateba CN.

Microorganisms. 2020 Jan 17;8(1). pii: E135. doi: 10.3390/microorganisms8010135. Review.

6.

Outcome, Return to Work and Health-Related Costs After Aneurysmal Subarachnoid Hemorrhage.

Seule M, Oswald D, Muroi C, Brandi G, Keller E.

Neurocrit Care. 2020 Jan 9. doi: 10.1007/s12028-019-00905-2. [Epub ahead of print]

PMID:
31919809
7.

A dataset on the effect of exercise-conditioned human sera in three-dimensional breast cancer cell culture.

De Santi M, Baldelli G, Lucertini F, Natalucci V, Brandi G, Barbieri E.

Data Brief. 2019 Oct 21;27:104704. doi: 10.1016/j.dib.2019.104704. eCollection 2019 Dec.

8.

Use of hormones in doping and cancer risk.

De Santi M, Baldelli G, Brandi G; GSMS-SItI, Working Group on Movement Sciences for Health, Italian Society of Hygiene preventive Medicine and Public Health; WDPP, Working Group Doping Prevention Project.

Ann Ig. 2019 Nov-Dec;31(6):590-594. doi: 10.7416/ai.2019.2319.

9.

Listeriolysin O antibodies detection in pregnant women: results from an Italian pilot study.

Massacesi M, Oliva N, Pucci L, Brandi G, De Santi M.

Ann Ig. 2019 Jul-Aug;31(4):326-332. doi: 10.7416/ai.2019.2294.

10.

Radiotherapy or Chemoradiation in Unresectable Biliary Cancer: A Retrospective Study.

Bisello S, Buwenge M, Palloni A, Autorino R, Cellini F, Macchia G, Deodato F, Cilla S, Brandi G, Tagliaferri L, Cammelli S, Valentini V, Morganti AG, Mattiucci GC.

Anticancer Res. 2019 Jun;39(6):3095-3100. doi: 10.21873/anticanres.13445.

PMID:
31177154
11.

BAP1 in solid tumors.

Di Nunno V, Frega G, Santoni M, Gatto L, Fiorentino M, Montironi R, Battelli N, Brandi G, Massari F.

Future Oncol. 2019 Jun;15(18):2151-2162. doi: 10.2217/fon-2018-0915. Epub 2019 Jun 4. Review.

PMID:
31159579
12.

Microbiota: Overview and Implication in Immunotherapy-Based Cancer Treatments.

Brandi G, Frega G.

Int J Mol Sci. 2019 May 31;20(11). pii: E2699. doi: 10.3390/ijms20112699. Review.

13.

Long Noncoding RNA SBF2-AS1 Is Critical for Tumorigenesis of Early-Stage Lung Adenocarcinoma.

Chen R, Xia W, Wang S, Xu Y, Ma Z, Xu W, Zhang E, Wang J, Fang T, Zhang Q, Dong G, Cho WC, Ma PC, Brandi G, Tavolari S, Ujhazy P, Metro G, Popper HH, Yin R, Qiu M, Xu L.

Mol Ther Nucleic Acids. 2019 Jun 7;16:543-553. doi: 10.1016/j.omtn.2019.04.004. Epub 2019 Apr 13.

14.

Chemopreventive Potential of Apple Pulp Callus Against Colorectal Cancer Cell Proliferation and Tumorigenesis.

Baldelli G, De Santi M, Fraternale D, Brandi G, Fanelli M, Schiavano GF.

J Med Food. 2019 Jun;22(6):614-622. doi: 10.1089/jmf.2018.0188. Epub 2019 May 6.

PMID:
31058564
15.

The Italian Rare Pancreatic Exocrine Cancer Initiative.

Brunetti O, Luchini C, Argentiero A, Tommasi S, Mangia A, Aprile G, Marchetti P, Vasile E, Casadei Gardini A, Scartozzi M, Barni S, Delfanti S, De Vita F, Di Costanzo F, Milella M, Cella CA, Berardi R, Cataldo I, Santini D, Doglioni C, Maiello E, Lawlor RT, Mazzaferro V, Lonardi S, Giuliante F, Brandi G, Scarpa A, Cascinu S, Silvestris N.

Tumori. 2019 Aug;105(4):353-358. doi: 10.1177/0300891619839461. Epub 2019 Apr 9.

PMID:
30967031
16.

The Human Microbiota and Prostate Cancer: Friend or Foe?

Massari F, Mollica V, Di Nunno V, Gatto L, Santoni M, Scarpelli M, Cimadamore A, Lopez-Beltran A, Cheng L, Battelli N, Montironi R, Brandi G.

Cancers (Basel). 2019 Mar 31;11(4). pii: E459. doi: 10.3390/cancers11040459. Review.

17.

An astonishing case of liver-only metastatic colorectal cancer cured by FOLFOXIRI alone.

Rizzo A, Palloni A, Frega G, Abbati F, De Lorenzo S, Brocchi S, Brandi G.

Anticancer Drugs. 2019 Apr;30(4):428-430. doi: 10.1097/CAD.0000000000000761.

PMID:
30875350
18.

Cholangiocarcinoma: Epidemiology and risk factors.

Khan SA, Tavolari S, Brandi G.

Liver Int. 2019 May;39 Suppl 1:19-31. doi: 10.1111/liv.14095. Epub 2019 Mar 24. Review.

PMID:
30851228
19.

Prediction of survival with second-line therapy in biliary tract cancer: Actualisation of the AGEO CT2BIL cohort and European multicentre validations.

Neuzillet C, Casadei Gardini A, Brieau B, Vivaldi C, Smolenschi C, Brandi G, Tougeron D, Filippi R, Vienot A, Silvestris N, Pointet AL, Lonardi S, Rousseau B, Scartozzi M, Dahan L, Aprile G, Boussaha T, Malka D, Crusz SM, Le Sourd S, Meurisse A, Lièvre A, Vernerey D; AGEO (Association des Gastro-Entérologues Oncologues); GICO (Italian Group of Cholangiocarcinoma) Investigators; Gustave Roussy Institute Cohort; Barts Cancer Institute Cohort.

Eur J Cancer. 2019 Apr;111:94-106. doi: 10.1016/j.ejca.2019.01.019. Epub 2019 Mar 1.

PMID:
30826661
20.

Combined Low Densities of FoxP3+ and CD3+ Tumor-Infiltrating Lymphocytes Identify Stage II Colorectal Cancer at High Risk of Progression.

Cavalleri T, Bianchi P, Basso G, Celesti G, Grizzi F, Bossi P, Greco L, Pitrone C, Valtorta E, Mauri G, Truini M, Dall'Olio FG, Brandi G, Sartore-Bianchi A, Ricciardiello L, Torri V, Rimassa L, Siena S, Mantovani A, Malesci A, Laghi L; Alleanza contro il Cancro (ACC) Colorectal Cancer Working Group.

Cancer Immunol Res. 2019 May;7(5):751-758. doi: 10.1158/2326-6066.CIR-18-0661. Epub 2019 Feb 25.

PMID:
30804005
21.

Cerebral metabolism is not affected by moderate hyperventilation in patients with traumatic brain injury.

Brandi G, Stocchetti N, Pagnamenta A, Stretti F, Steiger P, Klinzing S.

Crit Care. 2019 Feb 13;23(1):45. doi: 10.1186/s13054-018-2304-6.

22.

An atlas for clinical target volume definition, including elective nodal irradiation in definitive radiotherapy of biliary cancer.

Bisello S, Renzulli M, Buwenge M, Calculli L, Sallustio G, Macchia G, Deodato F, Mattiucci G, Cammelli S, Arcelli A, Giaccherini L, Cellini F, Brandi G, Guerri S, Cilla S, Golfieri R, Fuccio L, Morganti AG, Guido A.

Oncol Lett. 2019 Feb;17(2):1784-1790. doi: 10.3892/ol.2018.9774. Epub 2018 Nov 28.

23.

Stereotactic body radiation therapy in cholangiocarcinoma: a systematic review.

Frakulli R, Buwenge M, Macchia G, Cammelli S, Deodato F, Cilla S, Cellini F, Mattiucci GC, Bisello S, Brandi G, Parisi S, Morganti AG.

Br J Radiol. 2019 May;92(1097):20180688. doi: 10.1259/bjr.20180688. Epub 2019 Feb 7.

PMID:
30673295
24.

Ramucirumab after sorafenib in patients with advanced hepatocellular carcinoma and increased α-fetoprotein concentrations (REACH-2): a randomised, double-blind, placebo-controlled, phase 3 trial.

Zhu AX, Kang YK, Yen CJ, Finn RS, Galle PR, Llovet JM, Assenat E, Brandi G, Pracht M, Lim HY, Rau KM, Motomura K, Ohno I, Merle P, Daniele B, Shin DB, Gerken G, Borg C, Hiriart JB, Okusaka T, Morimoto M, Hsu Y, Abada PB, Kudo M; REACH-2 study investigators.

Lancet Oncol. 2019 Feb;20(2):282-296. doi: 10.1016/S1470-2045(18)30937-9. Epub 2019 Jan 18.

PMID:
30665869
25.

Hypothyroidism in patients with hepatocellular carcinoma receiving cabozantinib: an unassessed issue.

Di Nunno V, Frega G, Gatto L, Brandi G, Massari F.

Future Oncol. 2019 Feb;15(6):563-565. doi: 10.2217/fon-2018-0758. Epub 2019 Jan 16. No abstract available.

26.

Metformin prevents cell tumorigenesis through autophagy-related cell death.

De Santi M, Baldelli G, Diotallevi A, Galluzzi L, Schiavano GF, Brandi G.

Sci Rep. 2019 Jan 11;9(1):66. doi: 10.1038/s41598-018-37247-6.

27.

Membrane human equilibrative nucleoside transporter 1 is associated with a high proliferation rate and worse survival in resected intrahepatic cholangiocarcinoma patients not receiving adjuvant treatments.

Tavolari S, Deserti M, Vasuri F, Curti S, Palloni A, Pinna AD, Cescon M, Frega G, De Lorenzo S, Barbera MA, Garajova I, Ricciardiello L, Malvi D, D'Errico-Grigioni A, Pantaleo MA, Brandi G.

Eur J Cancer. 2019 Jan;106:160-170. doi: 10.1016/j.ejca.2018.11.005. Epub 2018 Dec 5.

28.

An exploratory study by DMET array identifies a germline signature associated with imatinib response in gastrointestinal stromal tumor.

Ravegnini G, Urbini M, Simeon V, Genovese C, Astolfi A, Nannini M, Gatto L, Saponara M, Ianni M, Indio V, Brandi G, Trino S, Hrelia P, Biasco G, Angelini S, Pantaleo MA.

Pharmacogenomics J. 2019 Aug;19(4):390-400. doi: 10.1038/s41397-018-0050-4. Epub 2018 Sep 20.

PMID:
30237583
29.

TUSC3 accelerates cancer growth and induces epithelial-mesenchymal transition by upregulating claudin-1 in non-small-cell lung cancer cells.

Feng S, Zhai J, Lu D, Lin J, Dong X, Liu X, Wu H, Roden AC, Brandi G, Tavolari S, Bille A, Cai K.

Exp Cell Res. 2018 Dec 15;373(1-2):44-56. doi: 10.1016/j.yexcr.2018.08.012. Epub 2018 Aug 9.

PMID:
30098333
30.

Bone metastases in biliary cancers: A multicenter retrospective survey.

Santini D, Brandi G, Aprile G, Russano M, Cereda S, Leone F, Lonardi S, Fornaro L, Scartozzi M, Silvestris N, Barni S, Pantano F, Vincenzi B, Palloni A, Frega G, Casagrande M, Ferrari L, Dadduzio V, Intini R, Filippi R, Vasile E, Vivaldi C, Faloppi L, Brunetti O, Reni M, Aglietta M, Tonini G.

J Bone Oncol. 2018 Apr 7;12:33-37. doi: 10.1016/j.jbo.2017.11.006. eCollection 2018 Sep.

31.

Metronomic capecitabine vs. best supportive care in Child-Pugh B hepatocellular carcinoma: a proof of concept.

De Lorenzo S, Tovoli F, Barbera MA, Garuti F, Palloni A, Frega G, Garajovà I, Rizzo A, Trevisani F, Brandi G.

Sci Rep. 2018 Jul 3;8(1):9997. doi: 10.1038/s41598-018-28337-6.

32.

Sustained complete response of advanced hepatocellular carcinoma with metronomic capecitabine: a report of three cases.

Brandi G, Venturi M, De Lorenzo S, Garuti F, Frega G, Palloni A, Garajovà I, Abbati F, Saccoccio G, Golfieri R, Pantaleo MA, Barbera MA.

Cancer Commun (Lond). 2018 Jun 26;38(1):41. doi: 10.1186/s40880-018-0312-1.

33.

The intrinsically disordered E-domains regulate the IGF-1 prohormones stability, subcellular localisation and secretion.

Annibalini G, Contarelli S, De Santi M, Saltarelli R, Di Patria L, Guescini M, Villarini A, Brandi G, Stocchi V, Barbieri E.

Sci Rep. 2018 Jun 11;8(1):8919. doi: 10.1038/s41598-018-27233-3.

34.

Alpha-fetoprotein kinetics in patients with hepatocellular carcinoma receiving ramucirumab or placebo: an analysis of the phase 3 REACH study.

Chau I, Park JO, Ryoo BY, Yen CJ, Poon R, Pastorelli D, Blanc JF, Kudo M, Pfiffer T, Hatano E, Chung HC, Kopeckova K, Phelip JM, Brandi G, Ohkawa S, Li CP, Okusaka T, Hsu Y, Abada PB, Zhu AX.

Br J Cancer. 2018 Jul;119(1):19-26. doi: 10.1038/s41416-018-0103-0. Epub 2018 May 29.

35.

Rapid and simultaneous detection of Salmonella spp., Escherichia coli O157, and Listeria monocytogenes by magnetic capture hybridization and multiplex real-time PCR.

Carloni E, Rotundo L, Brandi G, Amagliani G.

Folia Microbiol (Praha). 2018 Nov;63(6):735-742. doi: 10.1007/s12223-018-0617-0. Epub 2018 May 25.

PMID:
29797224
36.

Pulmonary hypertension is not a risk factor for grade 3 primary graft dysfunction after lung transplantation.

Cottini SR, Brandi G, Pagnamenta A, Weder W, Schuepbach RA, Béchir M, Huber LC, Benden C.

Clin Transplant. 2018 May;32(5):e13251. doi: 10.1111/ctr.13251. Epub 2018 Apr 30.

PMID:
29707826
37.

Ultraviolet germicidal irradiation in tap water contaminated by Aspergillus spp.

Sisti M, Schiavano GF, Santi M, Brandi G.

J Prev Med Hyg. 2017 Dec 30;58(4):E315-E319. doi: 10.15167/2421-4248/jpmh2017.58.4.777. eCollection 2017 Dec.

38.

Low Level of Vegetative State After Traumatic Brain Injury in a Swiss Academic Hospital.

Stretti F, Klinzing S, Ehlers U, Steiger P, Schuepbach R, Krones T, Brandi G.

Anesth Analg. 2018 Sep;127(3):698-703. doi: 10.1213/ANE.0000000000003375.

PMID:
29649031
39.

Integrated Molecular Characterization of Gastrointestinal Stromal Tumors (GIST) Harboring the Rare D842V Mutation in PDGFRA Gene.

Indio V, Astolfi A, Tarantino G, Urbini M, Patterson J, Nannini M, Saponara M, Gatto L, Santini D, do Valle IF, Castellani G, Remondini D, Fiorentino M, von Mehren M, Brandi G, Biasco G, Heinrich MC, Pantaleo MA.

Int J Mol Sci. 2018 Mar 4;19(3). pii: E732. doi: 10.3390/ijms19030732.

40.

Ten-Year Survival after Liver Resection for Breast Metastases: A Single-Center Experience.

Ercolani G, Zanello M, Serenari M, Cescon M, Cucchetti A, Ravaioli M, Del Gaudio M, D'Errico A, Brandi G, Pinna AD.

Dig Surg. 2018;35(4):372-380. doi: 10.1159/000486523. Epub 2018 Jan 24.

PMID:
29393171
41.

Detection of Shiga toxin-producing Escherichia coli (STEC) in ground beef and bean sprouts: Evaluation of culture enrichment conditions.

Amagliani G, Rotundo L, Carloni E, Omiccioli E, Magnani M, Brandi G, Fratamico P.

Food Res Int. 2018 Jan;103:398-405. doi: 10.1016/j.foodres.2017.10.059. Epub 2017 Oct 31.

PMID:
29389629
42.

Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation.

Trevisani F, Brandi G, Garuti F, Barbera MA, Tortora R, Casadei Gardini A, Granito A, Tovoli F, De Lorenzo S, Inghilesi AL, Foschi FG, Bernardi M, Marra F, Sacco R, Di Costanzo GG.

J Cancer Res Clin Oncol. 2018 Feb;144(2):403-414. doi: 10.1007/s00432-017-2556-6. Epub 2017 Dec 16.

PMID:
29249005
43.

Prevalence and antibiotic resistance of Pseudomonas aeruginosa in water samples in central Italy and molecular characterization of oprD in imipenem resistant isolates.

Schiavano GF, Carloni E, Andreoni F, Magi S, Chironna M, Brandi G, Amagliani G.

PLoS One. 2017 Dec 6;12(12):e0189172. doi: 10.1371/journal.pone.0189172. eCollection 2017.

44.

Occupational exposure to asbestos and risk of cholangiocarcinoma: a population-based case-control study in four Nordic countries.

Farioli A, Straif K, Brandi G, Curti S, Kjaerheim K, Martinsen JI, Sparen P, Tryggvadottir L, Weiderpass E, Biasco G, Violante FS, Mattioli S, Pukkala E.

Occup Environ Med. 2018 Mar;75(3):191-198. doi: 10.1136/oemed-2017-104603. Epub 2017 Nov 13.

45.

Brain Metastases from Biliary Tract Cancer: A Monocentric Retrospective Analysis of 450 Patients.

Frega G, Garajová I, Palloni A, Barbera MA, Trossello Pastore M, Faccioli L, Spinardi L, De Lorenzo S, Cubelli M, Pantaleo MA, Biasco G, Brandi G.

Oncology. 2018;94(1):7-11. doi: 10.1159/000479929. Epub 2017 Oct 13.

PMID:
29024931
46.

Mucosa-associated microbiota dysbiosis in colitis associated cancer.

Richard ML, Liguori G, Lamas B, Brandi G, da Costa G, Hoffmann TW, Pierluigi Di Simone M, Calabrese C, Poggioli G, Langella P, Campieri M, Sokol H.

Gut Microbes. 2018 Mar 4;9(2):131-142. doi: 10.1080/19490976.2017.1379637. Epub 2017 Oct 12.

47.

The role of metronomic capecitabine for treatment of recurrent hepatocellular carcinoma after liver transplantation.

Ravaioli M, Cucchetti A, Pinna AD, De Pace V, Neri F, Barbera MA, Maroni L, Frega G, Palloni A, De Lorenzo S, Ripoli MC, Pantaleo MA, Cescon M, Del Gaudio M, Brandi G.

Sci Rep. 2017 Sep 12;7(1):11305. doi: 10.1038/s41598-017-11810-z.

48.

Disinfection of Mycobacterium avium subspecies hominissuis in drinking tap water using ultraviolet germicidal irradiation.

Schiavano GF, De Santi M, Sisti M, Amagliani G, Brandi G.

Environ Technol. 2018 Dec;39(24):3221-3227. doi: 10.1080/09593330.2017.1375028. Epub 2017 Sep 13.

PMID:
28862077
49.

Oral oxycodone/naloxone for pain control in cirrhosis: Observational study in patients with symptomatic metastatic hepatocellular carcinoma.

Tovoli F, De Lorenzo S, Samolsky Dekel BG, Piscaglia F, Benevento F, Brandi G, Bolondi L.

Liver Int. 2018 Feb;38(2):278-284. doi: 10.1111/liv.13546. Epub 2017 Sep 4.

PMID:
28792650
50.

Non-Coding RNAs as Predictive Biomarkers to Current Treatment in Metastatic Colorectal Cancer.

Garajová I, Ferracin M, Porcellini E, Palloni A, Abbati F, Biasco G, Brandi G.

Int J Mol Sci. 2017 Jul 17;18(7). pii: E1547. doi: 10.3390/ijms18071547. Review.

Supplemental Content

Loading ...
Support Center